Relationship between α1-adrenergic receptor-induced contraction and extracellular signal-regulated kinase activation in the bovine inferior alveolar artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 1, 2002, Pages 403-411

  Hague, Chris ^a   Gonzalez Cabrera, Pedro J ^a   Jeffries, William B ^a   Abel, Peter W ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 (4 HYDROXYPHENYL)ETHYLAMINOMETHYL]TETRALONE; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NORADRENALIN; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CATTLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENCY; DRUG SELECTIVITY; ENZYME ACTIVITY; LUNG ALVEOLUS; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; WESTERN BLOTTING;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CATTLE; DESIPRAMINE; ENZYME ACTIVATION; HYDROCORTISONE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE CONTRACTION; NOREPINEPHRINE; PULMONARY ALVEOLI; PULMONARY ARTERY; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0036784533     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.037531     Document Type: Article

References (45)

1. 1-Adrenergic receptor binding and contraction of rat caudal artery. J Pharmacol Exp Ther 239:678-686.
2. Adam LP, Haeberle JR, and Hathaway DR (1989) Phosphorylation of caldesmon in arterial smooth muscle. J Biol Chem 264:7698-7703.
3. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
4. 2A receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J Pharmacol Exp Ther 291:1179-1187.
5. Bevan RD (1975) Effect of sympathetic denervation on smooth muscle cell proliferation in the growing rabbit ear artery. Circ Res 37:14-19.
6. Blase N and Boissel JP (1983) Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol 116:167-172.
7. 2-Adrenoceptor subtype causing nitric oxide-mediated vascular relaxation in rats. J Pharmacol Exp Ther 278:1235-1243.
8. Bradley JC (1972) Age changes in the vascular supply of the mandible. Br Dent J 132:142-144.
9. Bradley JC (1975) A radiological investigation into the age changes of the inferior dental artery. Br J Oral Surg 13:82-90.
10. 1-adrenoceptor subtypes. Br J Pharmacol 117:703-711.
11. 1-adrenoceptor subtypes in vitro and in situ. J Biol Chem 270:30980-30988.
12. Dessy C, Kim I, Sougnez CL, LaPorte R, and Morgan KG (1998) A role for MAP kinase in differentiated smooth muscle contraction evoked by α-adrenoceptor stimulation. Am J Physiol 275:C1081-C1086.
13. DiSalvo J, Steusloff A, Semenchuk L, Satoh S, Kolquist K, and Pfitzer G (1993) Tyrosine kinase inhibitors suppress agonist induced contraction in smooth muscle. Biochem Biophys Res Commun 190:968-974.
14. 2-adrenoceptors. Eur J Pharmacol 361:1-15.
15. Epstein AM, Throckmorton D, and Brophy CM (1997) Mitogen-activated protein kinase activation: an alternate signaling pathway for sustained vascular smooth muscle contraction. J Vasc Surg 26:327-332.
16. Faber JE, Yang N, and Xin X (2001) Expression of α-adrenoceptor subtypes by smooth muscle cells and adventitial fibroblasts in rat aorta and in cell culture. J Pharmacol Exp Ther 298:441-452.
17. 2A receptor signal transduction. J Pharmacol Exp Ther 284:346-355.
18. Fronek K, Bloor CM, Amiel D, and Chvapil M (1978) Effect of long-term sympathectomy on the arterial wall in rabbits and rats. Exp Mol Pathol 28:279-289.
19. 1B-adrenoceptor antagonist. Eur J Pharmacol 287:13-16.
20. Hague C, Smith DD, and Abel PW (2000) Adrenergic and CGRP receptor responses of bovine inferior alveolar artery. FASEB J 14:A1413.
21. 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br J Pharmacol 97:691-700.
22. Head RJ (1991) Hypernoradrenergic innervation and vascular smooth muscle hyperplastic change. Blood Vessels 28:173-178.
23. Hedges JC, Oxhorn BC, Carty M, Adam LP, Yamboliev IA, and Gerthoffer WT (2000) Phosphorylation of caldesmon by ERK MAP kinases in smooth muscle. Am J Cell Physiol 278:C718-C726.
24. 1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther 290:452-463.
25. 1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine kinases and calcium in activation of mitogen-activated protein kinase. J Pharmacol Exp Ther 290:28-37.
26. Jin N, Siddiqui RA, English D, and Rhoades RA (1996) Communication between tyrosine kinase pathway and myosin light chain kinase pathway in smooth muscle. Am J Physiol 271:H1348-H1355.
27. Lee RMKW, Triggle CR, Cheung DWT, and Coughlin MD (1987) Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. Hypertension 10:328-338.
28. 1-adrenergic receptor subtypes. Mol Pharmacol 46: 929-936.
29. 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol 37:30-36.
30. 1D-AR to the contraction of vascular smooth muscle. J Pharmacol Exp Ther 275:1583-1589.
31. 1B-AR and the contribution of this and the other subtypes to vascular smooth muscle contraction: analysis with selective ligands and antisense oligonucleotides. J Pharmacol Exp Ther 283:854-868.
32. Post GR, Goldstein D, Thuerauf DJ, Glembotski CC, and Brown JH (1996) Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 271:8452-8457.
33. Robinson MJ and Cobb MH (1997) Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9:180-186.
34. 1Dsubtype. J Pharmacol Exp Ther 278:136-144.
35. 1-adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J Pharmacol Exp Ther 275: 1035-1042.
36. 2D-adrenergic receptors in bovine pineal gland. Mol Pharmacol 40:235-241.
37. 1B-adrenoceptor antagonist, (+)cyclazosin. Eur J Pharmacol 361:79-83.
38. Stewart JM, Patel MB, Wang J, Ochoa M, Gewitz M, Loud AV, Anversa P, and Hintze TH (1992) Chronic elevation of norepinephrine in conscious dogs produces hypertrophy with no loss of LV reserve. Am J Physiol 262:H331-H339.
39. Thorburn J and Thorburn A (1994) The tyrosine kinase inhibitor, genistein, prevents α-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signaling pathway. Biochem Biophys Res Commun 202: 1586-1591.
40. 2and β-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J Biol Chem 273:24624-24632.
41. Xiao L and Jeffries WB (1998) Kinetics of alkylation of cloned rat alphaladrenoceptor subtypes by chlorethylclonidine. Eur J Pharmacol 347:319-327.
42. 1D-Adrenergic receptors and mitogen-activated protein kinase mediate increased protein synthesis by arterial smooth muscle. Mol Pharmacol 51:764-775.
43. 1-AR mediated contraction in the mouse thoracic aorta. Eur J Pharmacol 424:131-140.
44. 1-Adrenoceptor subtypes. Eur J Pharmacol 375:261-276.
45. Zoud K and Doran GA (1993) Microsurgical anatomy of the inferior alveolar neurovascular plexus. Surg Radiol Anat 15:175-179.